Company Filing History:
Years Active: 2011
Title: **The Innovative Journey of Martin Putala in Sartan Derivatives**
Introduction
Martin Putala, a notable inventor based in Bratislava, Slovakia, has made significant contributions to the field of pharmaceuticals through his pioneering work on sartan derivatives. His innovative approach highlights the potential for advancements in therapeutic agents essential for various medical applications.
Latest Patents
Putala holds a patent for a process aimed at the preparation of sartan derivatives and intermediates, detailed as "Process for the preparation of sartan derivatives and intermediates useful in such process." This patent encompasses a method involving the reaction of 2-cyanophenylboronic acid or its derivatives with a p-halobenzyl-1H-imidazole derivative, utilizing a transition metal catalyst and an inorganic or organic base. The invention not only provides a pathway for creating sartan derivatives but also introduces new intermediates valuable for pharmaceutical research.
Career Highlights
With one patent to his name, Martin Putala has established a remarkable career in pharmaceutical research and development. His work at Krka, d.d., Novo Mesto, a renowned company in the pharmaceutical industry, has enabled him to focus on creating innovative solutions that address pressing healthcare needs.
Collaborations
During his career, Martin has collaborated with notable colleagues such as Miroslav Veverka and Heinrich Brath. Together, they have fostered a dynamic environment that encourages innovation and the exploration of new medicinal compounds, further enriching the pharmaceutical landscape.
Conclusion
In summary, Martin Putala exemplifies the spirit of innovation within the pharmaceutical industry through his dedicated research and development efforts. His patented process for preparing sartan derivatives not only enhances therapeutic options but also underscores the importance of collaboration among skilled professionals in advancing healthcare solutions.